Dow Down 0.22% Nasdaq Up 0.14%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
9.76 Up 0.29(3.06%) Aug 22, 4:00PM EDT
|After Hours : 9.78 Up 0.02 (0.20%) Aug 22, 7:46PM EDT
Prev Close:9.47
Open:9.49
Bid:9.75 x 700
Ask:9.79 x 500
1y Target Est:12.40
Beta:1.8
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:9.36 - 9.86
52wk Range:2.26 - 10.18
Volume:4,195,234
Avg Vol (3m):7,447,590
Market Cap:954.41M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNUp 3.06%954.41M
GSKDown 0.04%114.53B
JNJDown 0.38%290.77B
RHHBYDown 0.33%246.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.69
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-2.72

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback